Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Cervical cancer development involves complex genetic and molecular changes.
• MicroRNA (miRNA) expression patterns and their role in cervical carcinogenesis are not fully understood.
• Chromosomal instability is a hallmark of cancer, but its link to miRNA alterations in cervical cancer requires further investigation.

Purpose of the Study:

• To investigate miRNA expression profiles across consecutive stages of cervical squamous cell carcinoma (SCC) development.
• To correlate miRNA expression changes with chromosomal alterations in normal epithelium, precancerous lesions (CIN2-3), and invasive cervical cancers (SCCs and adenocarcinomas).
• To functionally characterize the role of specific differentially expressed miRNAs, particularly hsa-miR-9, in cervical carcinogenesis.

Main Methods:

• Integrated analysis of miRNA expression data with existing chromosomal profiles from cervical tissue samples.
• Identification of significantly differentially expressed miRNAs during cervical SCC progression.
• Functional assays including in vitro cell viability, anchorage-independent growth, migration, and organic raft culturing to assess hsa-miR-9's oncogenic potential.

Main Results:

• 106 miRNAs exhibited significantly differential expression during cervical SCC development.
• 27 miRNAs showed early transient changes in CIN2-3, 46 late changes in SCCs, and 33 continuous changes.
• Five miRNAs, including hsa-miR-9, showed altered expression linked to chromosomal aberrations; hsa-miR-9 overexpression, associated with a 1q gain, enhanced cell viability, growth, migration, and disrupted epithelial differentiation.

Conclusions:

• Differential miRNA expression is a significant feature of cervical carcinogenesis, with specific miRNAs associated with disease progression.
• Chromosomal alterations contribute to the dysregulation of miRNA expression in cervical cancer.
• Hsa-miR-9 acts as a potential oncogene, promoting cervical cancer development through enhanced proliferation and impaired differentiation, highlighting the clinical relevance of miRNA deregulation.